Gornitzky & Co.

Testimonials

Collated independently by Legal 500 research team.

• We work most closely with Yuval Horn, who is without question one of the leading figures in Israel’s life sciences legal market. Yuval’s strength lies in his ability to bridge science, law, and business — he understands the regulatory and commercial context as well as the legal framework and translates that into clear, practical advice. His foresight and ability to anticipate challenges set him apart from competitors and give us great confidence in his guidance. The wider team, including the associates we have worked with, is equally impressive — responsive, detail-oriented, and pragmatic. They are collaborative and accessible and consistently deliver solutions that reflect a deep understanding of both our business and the broader life sciences ecosystem. It is this combination of technical excellence, commercial awareness, and client focus that makes Gornitzky’s team unique in the market.
• Very professional, fast, and understanding of my needs.
• Very professional, good availability, no wasting time.
• As clients of Horn & Co., we were pleased to see the team join forces with Gornitzky, one of Israel’s most established and respected firms. The merger has enhanced the relationship — combining Horn’s unrivaled licensing and high-tech expertise, led by Yuval Horn, with Gornitzky’s scale, multidisciplinary resources, and international reach. For us, this means continuity with trusted advisors who understand our business, now backed by the resources to handle transactions of unprecedented scale and complexity. What makes them stand out is their ability to bridge science and law. They understand the science, the regulatory landscape, and the commercial realities, and translate all of that into practical, enforceable agreements that protect our interests and help our portfolio companies grow. In our experience, no other firm in Israel combines such deep life sciences expertise with international sophistication and a truly client-focused approach.
• ‘The merger with Horn & Co. has enhanced client relationships, combining Horn’s unrivalled licensing and hi-tech expertise, led by Yuval Horn, with Gornitzky’s scale, multidisciplinary resources, and international reach.’
• ‘The merger means continuity with trusted advisers who understand clients’ business, and are now backed by the resources to handle transactions of unprecedented scale and complexity.’
• ‘What makes them stand out is their ability to bridge science and law. They understand the science, the regulatory landscape, and the commercial realities, and translate all of that into practical, enforceable agreements that protect clients’ interests and help portfolio companies grow.’
• ‘No other firm in Israel combines such deep life sciences expertise with international sophistication and a truly client-focused approach.’
• ‘The team, including the associates, is impressive - responsive, detail oriented, and pragmatic.’
• ‘They are collaborative, accessible, and consistently deliver solutions that reflect a deep understanding of both clients’ business and the broader life sciences ecosystem. It is this combination of technical excellence, commercial awareness, and client focus that makes Gornitzky’s team unique in the market.’

Key clients

• Group 11
• Bridgewise
• Boston Scientific Corporation
• Rapyd Financial Networks (2016)
• V-Wave
• Ibex Israel VC
• Pontifax Venture Capital Fund
• Tal Ventures
• Ingredion
• Samsung Venture Investment Company
• Eitan Medical
• The INX Digital Company
• Ossio
• aMoon
• Luminescent Heat Engine
• Nugen
• Lutris Pharma
• Deliverider
• QuBind Technologies Corp
• A.R. Guide In Medical

Work highlights

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Shlomo Landress

Yuval Horn